about
Approaches for dosage individualisation in critically ill patients.Evaluating amikacin dosage regimens in intensive care unit patients: a pharmacokinetic/pharmacodynamic analysis using Monte Carlo simulation.Influence of formulation on propofol pharmacokinetics and pharmacodynamics in anesthetized patients.Pharmacokinetics and dosing requirements of digoxin in pregnant women treated for fetal supraventricular tachycardia.A New Method for Individualized Digoxin Dosing in Elderly Patients.Usalpharma: a cloud-based architecture to support quality assurance training processes in health area using virtual worlds.[Digoxin-propafenone interaction]Interaction between digoxin and propafenoneDigoxin pharmacokinetics in patients with high serum digoxin concentrationsMinimizing digoxin-like immunoreactivity with TDx digoxin in dialysis patientsPopulation pharmacokinetics of digoxin in pediatric patientsModification of the EMIT immunoassay for the measurement of unbound mycophenolic acid in plasmaTherapeutic drug monitoring of tumour necrosis factor inhibitors in the management of chronic inflammatory diseasesA 3-year prospective study of a multidisciplinary early proactive therapeutic drug monitoring programme of infliximab treatments in inflammatory bowel diseaseVancomycin Pharmacokinetics Throughout Life: Results from a Pooled Population Analysis and Evaluation of Current Dosing RecommendationsEvaluation of renal function equations to predict amikacin clearance
P50
Q38125209-4C05074E-A703-492C-BC51-116DB5C9597BQ43855514-A78FE8F2-E8A4-4578-8B10-822C1973CA10Q45021462-C8FF3B21-E524-4BD1-9941-95FB63CA991FQ47795256-EE729C06-49AB-4559-BCDC-B951251BE196Q50722266-FED29E66-F79E-4AA1-A0E1-6469C1191FC9Q55442823-2ED7F8F8-68EB-4B5E-935B-C1F563133B1AQ69235757-F82EDCC8-9ABE-4FDD-8D1D-0B1254B26429Q69937946-AEF295BC-E28B-4A18-B18C-0690CD186971Q70660276-CFA19528-49BE-4FB3-A04D-442E341904D8Q73453711-2C9F08DC-9943-4BEC-9F64-84A938C41025Q78571419-B7C2127C-F55F-429D-9176-491B6F3FCBD1Q85159965-A8D6A07B-494F-4ACC-9583-917203136611Q88883428-81317CA9-D5ED-4BE0-9D82-D9C198E5E253Q89542295-0CE1D983-FA3B-435D-B9E3-0C89875995FEQ91104430-2B818C44-92C6-4FBB-8BEA-1C4CD2E81B6EQ93044931-14F2A58E-50DA-434A-8313-1AACDD3337A5
P50
description
researcher
@en
name
Ana Martín Suárez
@en
Martín Suárez A
@ast
Martín Suárez A
@nl
type
label
Ana Martín Suárez
@en
Martín Suárez A
@ast
Martín Suárez A
@nl
altLabel
Martín Suárez A
@en
prefLabel
Ana Martín Suárez
@en
Martín Suárez A
@ast
Martín Suárez A
@nl
P106
P31
P496
0000-0002-8191-0465